Continuous Localization Agile CI/CD – SOFTWARE LOCALIZATION

Continuous Localization in Agile CI/CD Pipelines: Eliminating the Release Bottleneck

/0 Comments/in , /by

Modern SaaS and mobile engineering teams deploying code multiple times a day can no longer wait for traditional waterfall translation handoffs. Continuous localization integrates TMS platforms directly with Git repositories to automate string extraction and delivery.

Why Waterfall Localization Fails in Agile Software Development

In traditional software engineering, localization was historically scheduled during a ‘string freeze’ just days before a major version release. Engineers exported resource files—such as JSON, XLIFF, Android XML, or iOS `.strings`—emailed spreadsheets to translation vendors, and manually re-imported translated files. In modern Agile and DevOps environments where features are shipped continuously via CI/CD pipelines, manual file handoffs create engineering bottlenecks, broken builds from corrupted placeholders, and delayed international product launches.

Continuous Localization Agile CI/CD – SOFTWARE LOCALIZATION
SOFTWARE LOCALIZATION — Professional Localization & Regulatory Quality Assurance (May 27, 2021)

Automating Resource File Sync with Git Connectors and Webhooks

Continuous localization resolves this friction by connecting the Translation Management System (TMS) directly to GitHub, GitLab, or Bitbucket repositories via webhooks and CLI tools. Whenever a developer merges a pull request containing new UI strings into the main branch, the TMS automatically detects the delta, assigns the strings to linguists with automated screenshot context and Translation Memory pre-translation, runs automated QA checks on tags and variables (such as `%s` or `{count}`), and pushes completed translations back as a branch merge.

Executive Takeaways for Global Enterprises

  • Key Insight: Git-integrated TMS connectors eliminate manual file exports and keep multilingual UI strings synchronized with agile sprints.
  • Key Insight: Visual context (automated UI screenshots and character-length limits) reduces linguistic queries and prevents text truncation.
  • Key Insight: Automated QA checks validate code placeholders, ICU MessageFormat syntax, and HTML tags before translations are merged into production.

Need certified multilingual translations, sworn legal asseverations, or ISO-compliant localization for your international projects? Request a free customized quotation from Alphatrad and receive a detailed turnaround plan within 24 hours.

Editorial & Copyright Attribution Note: This industry analysis has been independently synthesized and adapted by Alphatrad’s editorial team based on verified regulatory documentation and industry research originally published by Phrase Blog. For the original publication and primary documentation, please consult:
Source: https://phrase.com/blog/posts/continuous-localization/

EU MDR 2017/745 Language Requirements – MEDICAL DEVICES & MDR

EU Medical Device Regulation (MDR 2017/745) Enters Into Application: Language Requirements Explained

/0 Comments/in , /by

As Regulation (EU) 2017/745 (EU MDR) officially becomes applicable on May 26, 2021, medical device manufacturers face stringent mandatory translation obligations across up to 24 official EU languages for labels, IFUs, and Summaries of Safety and Clinical Performance (SSCP).

Article 10(11) and National Language Mandates Across EU Member States

On May 26, 2021, following a one-year postponement due to the pandemic, the European Union Medical Device Regulation—Regulation (EU) 2017/745 (MDR)—officially enters into application, replacing the legacy Medical Devices Directive (93/42/EEC). Under Article 10(11) of the MDR, manufacturers must supply device labels and Instructions for Use (IFUs) in the official Union language(s) determined by each Member State in which the device is made available to the user or patient. Because language content is now scrutinized prior to CE marking approval by Notified Bodies, translation can no longer be treated as a post-certification afterthought.

EU MDR 2017/745 Language Requirements – MEDICAL DEVICES & MDR
MEDICAL DEVICES & MDR — Professional Localization & Regulatory Quality Assurance (May 12, 2021)

New Content Requirements: SSCP, Implant Cards, and EUDAMED

The MDR introduces entirely new categories of multilingual documentation. For Class III and implantable devices, Article 32 requires a Summary of Safety and Clinical Performance (SSCP) written in a way that is clear to the intended user and, where relevant, the patient—translated into the languages of all target Member States and uploaded to the EUDAMED database. Maintaining strict ISO 13485 and ISO 17100 quality management processes, locked terminology glossaries, and synchronized Translation Memories is essential for audit readiness.

Executive Takeaways for Global Enterprises

  • Key Insight: EU MDR (Regulation 2017/745) applies from May 26, 2021, requiring device information in up to 24 official EU languages depending on national laws.
  • Key Insight: Class III and implantable devices require a patient-accessible Summary of Safety and Clinical Performance (SSCP) validated for readability.
  • Key Insight: Notified Bodies audit translation quality management procedures (ISO 13485 / ISO 17100) as part of technical documentation conformity assessment.

Need certified multilingual translations, sworn legal asseverations, or ISO-compliant localization for your international projects? Request a free customized quotation from Alphatrad and receive a detailed turnaround plan within 24 hours.

Editorial & Copyright Attribution Note: This industry analysis has been independently synthesized and adapted by Alphatrad’s editorial team based on verified regulatory documentation and industry research originally published by European Commission – Public Health & Medical Devices. For the original publication and primary documentation, please consult:
Source: https://health.ec.europa.eu/medical-devices-sector/new-regulations_en

Clinical Trial Localization Pharmacovigilance – LIFE SCIENCES

Multilingual Clinical Trial Localization and Pharmacovigilance in Global Vaccine Rollouts

/0 Comments/in , /by

Unprecedented timelines for global clinical trials and vaccine distribution in 2021 have placed life sciences translation at the center of public health—requiring rapid linguistic validation of Informed Consent Forms (ICFs) and 24/7 adverse event reporting.

Accelerating Multi-Regional Clinical Trials Without Compromising Compliance

In the first half of 2021, multinational pharmaceutical sponsors and Contract Research Organizations (CROs) have operated under compressed regulatory timelines to execute Phase III clinical trials and post-authorization safety studies across Europe, Latin America, and Asia-Pacific. Every clinical study protocol, Investigator’s Brochure (IB), and patient-facing Informed Consent Form (ICF) must be translated and adapted for local Ethics Committees (IRBs/IECs) in full compliance with Good Clinical Practice (ICH E6 R2) and ISO 17100 standards.

Clinical Trial Localization Pharmacovigilance – LIFE SCIENCES
LIFE SCIENCES — Professional Localization & Regulatory Quality Assurance (April 22, 2021)

Linguistic Validation of ePROs and Real-Time Pharmacovigilance

As trials increasingly rely on electronic Patient-Reported Outcomes (ePRO) and mobile health diaries, translators must perform rigorous linguistic validation—including dual forward translation, reconciliation, back-translation, and cognitive debriefing with native patients—to ensure conceptual equivalence across cultures. Simultaneously, global pharmacovigilance teams require rapid 24-hour translation of Suspected Unexpected Serious Adverse Reactions (SUSARs) and Periodic Safety Update Reports (PSURs) coded accurately against MedDRA (Medical Dictionary for Regulatory Activities) terminology.

Executive Takeaways for Global Enterprises

  • Key Insight: Linguistic validation of Patient-Reported Outcomes (PRO/eCOA) follows strict ISPOR and FDA/EMA dual-forward and back-translation protocols.
  • Key Insight: Pharmacovigilance adverse event reporting demands rapid turnaround times and strict adherence to official MedDRA terminology.
  • Key Insight: Certified medical translators play a critical role in patient comprehension and ethical informed consent across diverse populations.

Need certified multilingual translations, sworn legal asseverations, or ISO-compliant localization for your international projects? Request a free customized quotation from Alphatrad and receive a detailed turnaround plan within 24 hours.

Editorial & Copyright Attribution Note: This industry analysis has been independently synthesized and adapted by Alphatrad’s editorial team based on verified regulatory documentation and industry research originally published by Slator Life Sciences. For the original publication and primary documentation, please consult:
Source: https://slator.com/life-sciences/